A Potential Role for APLP2 in Axogenesis
Total Page:16
File Type:pdf, Size:1020Kb
The Journal of Neuroscience, October 1995, 15(10): 63144326 Distribution of an APP Homolog, APLP2, in the Mouse Olfactory System: A Potential Role for APLP2 in Axogenesis Gopal Thinakaran,1,5 Cheryl A. Kitt, 1,5 A. Jane I. Roskams,” Hilda H. Slunt,1,5 Eliezer Masliah,’ Cornelia von Koch,2,5 Stephen D. Ginsberg,i,5 Gabriele V. Ronnett,‘s4 Randall Ft. Reed,233I6 Donald L. Price,‘,2.4,5 and Sangram S. Sisodiaiz5 ‘Departments of Pathology, 2Neuroscience, 3Molecular Biology and Genetics, and 4Neurology, 5Neuropathology Laboratory, and the 6Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205 and ‘Departments of Neurosciences and Pathology and Neuroscience, University of California at San Diego, La Jolla, California 92093 Deposition of l3-amyloid (AS) in senile plaques is a major APLP2, alternative splicing, chondroitin sulfate glycosami- pathological characteristic of Alzheimer’s disease. Ap is noglycan, glomeruli, olfactory epithelium, o/factory sen- generated by proteolytic processing of amyloici precursor sory neurons] proteins (APP). APP is a member of a family of related poly- peptides that includes amyloid precursor-like proteins A principal pathological feature of Alzheimer’s disease is the APLPl and APLPS. To examine the distribution of APLP2 deposition of Al3 in brain parenchyma (Glenner and Wong, in the nervous system, we generated antibodies specific 1984; Masters et al., 1985). Al3, an -4 kDa polypeptide, is for APLPS and used these reagents in immunocytochemi- derived from larger type I integral membrane glycoproteins, cal and biochemical studies of the rodent nervous system. termed the amyloid precursor proteins (APP) (Kang et al., 1987; In this report, we document that in cortex and hippocam- Kitaguchi et al., 1988; Ponte et al., 1988; Tanzi et al., 1988; pus, APLPS is enriched in postsynaptic compartments. In Golde et al., 1990; K&rig et al., 1992). APP is a member of a the olfactory system, however, APLPS is abundant in ol- family of homologous amyloid precursor-like proteins (APLPs), factory sensory axons, and axon terminals in glomeruli. including APLPl (Wasco et al., 1992) and APLP2 (Sprecher et Confocal microscopy revealed that APLPP is present in al., 1993; Wasco et al., 1993; Slunt et al., 1994). Although the both pre- and postsynaptic compartments in the olfactory members of this gene family share considerable homology in the bulb. Notably, mRNA encoding chondroitin sulfate glycos- amino- and carboxyl-terminal domains, the APLPs differ from aminoglycan (CS GAG)-modified forms of APLPS are en- APP by the absence of the Al3 region. riched in the olfactory epithelium, relative to alternatively- At present, APLP2 is the best characterized member of spliced mRNA, encoding CS GAG-free forms of APLPP. In APLPs. Like APP APLP2 is encoded by several mRNAs de- addition, we demonstrate that CS-modified APLPS forms rived by alternative splicing (Wasco et al., 1993; Sandbrink et accumulate in the olfactory bulb. CS proteoglycans are al., 1994; Slunt et al., 1994). Both APP and APLP2 are ex- known to play an important role in regulating cell migration pressed in brain and peripheral tissues (Wasco et al., 1993; Slunt and neuronal outgrowth. Since sensory neurons in the ol- et al., 1994), and in situ hybridization studies disclose similari- factory epithelium are in a state of continual turnover, ax- ties in the distributions of APP and APLP2 mRNAs in mouse ons of newly generated cells must establish synaptic con- (Slunt et al., 1994) and human (Wasco et al., 1993) CNS. Fi- nections with neurons in the olfactory bulb in adult life. The nally, APLP2 matures through the same unusual secreto- presence of APLPS in olfactory sensory axons and glo- ry/cleavage pathway as APP (Slunt et al., 1994). However, in meruli is consistent with the view that this protein may play contrast to APP-695 and APP-7511770, APLP2-751 is a sub- an important role in axonal pathfinding and/or synaptoge- strate for modification by a single CS GAG chain (Thinakaran nesis. and Sisodia, 1994). [Key words: amyloid precursor-like protein 2, APP, In this study, we report on the distribution of APLP2 in the rodent nervous system using newly generated antibodies specific for APLP2. Consistent with previous in situ hybridization stud- Received Apr. 3, 1995; revised May 22, 1995; accepted May 31, 1995. The CT12 peptide was obtained from the Protein Sequencing and Peptide ies (Slunt et al., 1994), our investigations with the APLPZspe- Synthesis Core maintained by the Center for AIDS Research at Johns Hopkins cific antibodies revealed that APLP2 is expressed in a variety of University School of Medicine under Contract Number 1P30 Al28748 from regions, including cerebral cortex, hippocampus, and thalamus. the National Institute for Allergy and Infectious Diseases of the NIH. We thank Drs. Samuel Gandy, Mike Lee, and Philip Wong for providing antibodies 369, Confocal microscopy revealed prominent colocalization of TuJl, and Myc-I, respectively; Karen Schrader for providing mouse olfactory APLP2 with MAP-2, a postsynaptic marker, in cortex and hip- epithelium RNA; Dr. David Borchelt for providing APP-695 cDNA; and Dr. pocampus. Moreover, APLP2 mRNA is highly expressed in sen- Wilma Wasco for providing the APLPI cDNA. This work was supported by grants from the NIA, NINDS, American Health Assistance Foundation, Al- sory neurons in the olfactory epithelium, and the encoded poly- zheimer’s Association, and the Adler Foundation. peptide is abundant in olfactory sensory axons, and axon ter- Corresoondence should be addressed to Dr. Sanaram S. Sisodia. The Johns Hopkins University School of Medicine, Neuropathilogy Laboratory, 558 Ross minals in glomeruli. In contrast to its predominant postsynaptic Research Building, 720 Rutland Avenue, Baltimore, MD 21205-2196. localization in neurons in cortex and hippocampus, APLP2 is Copyright 0 1995 Society for Neuroscience 0270-6474/95/156314-13$05.00/O present in both pre- and postsynaptic compartments in the ol- The Journal of Neuroscience, October 1995, 75(10) 6315 factory bulb. Notably, mRNA encoding CS GAG-modified cells,an African greenmonkey kidney line, weretransiently transfected forms of APLP2 are highly represented in the olfactory epithe- in 60 mm plates with 10 pg of CsCl-purified plasmid DNA using a high-efficiency calcium phosphate method (Chen and Okayama, 1987). hum, and CS GAG modified forms of APLP2 accumulate in the Thirty-six hours after transfection, cells were labeled with 200 l&i/ml olfactory bulb. Since olfactory sensory neurons are continually 35S-methionine (Du Pont NEN, Wilmington, DE) for 3 hr in Dulbecco’s turned over, axons of newly generated neurons must establish modified Eagle medium lacking methionine and supplemented with 1% synaptic connections with neurons in the olfactory bulb in adult dialyzed fetal calf serum. Detergent lysates and conditioned medium prepared from labeled cells were subject to immunoprecipitation anal- life. Taken together with the view that CS proteoglycans play isis as described (Sisodia et al., 1996; Slunt et al., 1994):CT12, D2-I, an important role in regulating cell migration and neuronal out- and D2-II antibodies were used at 1:2500 dilution for Western blot growth (for review, see Wight et al., 1992), the unique localiza- analysis of lysates prepared from cells transiently expressing APP, tion of APLP2 in olfactory sensory axons and glomemli is con- APLPl, or APLP2. sistent with the notion that this protein may play an important In situ hybridization. Sequences that encode residues 568-681 of mouse APLP2 were cloned into Bluescript KS+ (Slunt et al., 1994) and role in axonal pathfinding and/or synaptogenesis. used as templates to generate sense or antisense 33P-labeled riboprobes using a RNA transcription kit (Stratagene, La Jolla, CA). Sections (10 Materials and Methods pm) cut from fixed frozen mouse nasal epithelium were dried onto slides coated with Fol’s mounting medium, fixed in 4% paraformalde- Antibodies. Ab369 is a polyclonalantibody raised against the entire hyde (PFA) for 20 min and rinsed in phosphate-buffered saline (PBS) cytoplasmic domain (residues 645-694) of APP-695 (Buxbaum et al., and deionized water. After acetylation in 0.25% acetic anhydride pre- 1990), and was kindly provided by Dr. Samuel Gandy (Cornell Uni- pared in 0.1 M triethanolamine, sections were rinsed in PBS and de- versity Medical College, New York). c-Myc-modified APLP2 polypep- hydrated through a graded series of alcohol, and then dried. Sections tides (Thinakaran and Sisodia, 1994) were immunoprecipitated using were hybridized overnight at 55°C in a buffer containing 50% formam- polyclonal antiserum Myc-I (provided by Dr. Philip Wong, Department ide, 10% dextran sulfate, 0.3 M NaCl, 20 mu Tris (pH 7.5), 10 mu of Pathology, The Johns Hopkins University School of Medicine, Bal- Dm, 5 mu EDTA, 1 X Denhardt’s solution and 0.4 mg/ml yeast tRNA, timore), raised against the synthetic peptide MEQKLISEEDLN (Lee et X al., 1993). and 1 rig/slideof labeledprobe (-2 lo6 cpm/ng).Slides were washed asfollows: 5 X SSC (1 X SSC = 0.15 M NaCl, 0.015 M sodium citrate) To generate polyclonal APLP2-specific antibody CT12, a synthetic X peptide corresponding to the C-terminal 12 amino acids (residues 740- and 1 mu D’IT at 55°Cfor 20 min; 50% formamide,2 SSC and 1 mu D’lT at 60°C for 30 min; 10 mu Tiis (pH 7.5), 0.5 M NaCl, and 5 75 1) of mouse APLP2-75 1 with an additional cysteine at the N-terminus mu EDTA (TNE buffer) at 37°C three times 10 min each; TNE buffer (CNPTYKYLEQMQI) was coupled to maleimide-activated keyhole containing 20 kg/ml RNase A at 37°C for 45 min; TNE buffer at 37°C limpet hemocyanin (Imject, Pierce Chemical Co., Rockford, IL). The for 15 min: 50% formamide.